Wow what a fantastic opportunity. Buy buy buy. This is cheap. pretty simple really. Major distribution deals and list goes on. Opportunity is short lived and this is our moment. gltash
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status